Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
NCT ID: NCT02550795
Last Updated: 2020-08-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2015-09-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer Surgery
NCT01548209
Effect of Dexamethasone in Postoperative Symptoms After Mastectomy for Breast Cancer
NCT01116713
Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery
NCT01007500
Dexamethasone Palmitate for PONV After Open Surgery
NCT06997419
Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery
NCT05408676
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
administration of 0.9% normal saline 10ml
Control
administration of normal saline
Dexmedetomidine
administration of 0.5ug/kg of dexmedetomidine (5ml)
Dexmedetomidine
administration of dexmedetomidine only
Dexmedetomidine and dexamethasone
administration of 0.5 ug/kg of dexmedetomidine and dexamethasone 5mg (total 5ml)
Dexmedetomidine and dexamethasone
administration of dexmedetomidine and dexamethasone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
administration of dexmedetomidine only
Dexmedetomidine and dexamethasone
administration of dexmedetomidine and dexamethasone
Control
administration of normal saline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* history of chronic pain
* smoker
* previous history of steroid administraion
* neoajuvant chemotherapy
20 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gachon University Gil Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Youn Yi Jo
Assistant professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GCIRB2014
Identifier Type: REGISTRY
Identifier Source: secondary_id
Breast PONV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.